Phillips-Medisize Corporation has completed a 10,000 sq. ft. expansion to their Czech Republic Facility. This facility expansion provides more cleanroom production space while increasing the total footprint of this facility to enhance existing capabilities. The FDA-registered and ISO 13485-certified facility provides plastic, liquid injection moulding, as well as catheter extrusion and full finished device assembly capabilities in class 7 and 8 cleanrooms. At Compamed that takes place 14 to 16 November in Düsseldorf, Germany, Phillips-Medisize will be presenting its competencies in drug delivery, medical device and diagnostic products such as disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components.
Matt Jennings, President and CEO of Phillips-Medisize Corp said, “We are very excited about the completion of this expansion. Our Czech facility is an important part of our strategy of providing state-of-the-art medical facilities, equipped with the latest technologies, to our customers in regions around the world.”
As a direct result of the new business wins, Phillips-Medisize has increased the staffing at the Czech facility by over 60%. Today, 138 professionals are focused on meeting the needs of medical device customers in Europe and North America who have entrusted the manufacturing of their products to the Phillips-Medisize Czech facility.
Visit Phillips-Medisize at Compamed next week in hall 8a, stand H15.Yvonne Klöpping